News
Delivered as a once-daily 30 mg/mL IV bolus injection over 15 seconds, Xifyrm can be used alone or alongside non-NSAID ...
Strengthening CMC leadership to prepare for scaled up neflamapimod manufacturing On track to initiate Phase 3 trial of neflamapimod in DLB ...
Valence and nonvalence vertex functions for timelike and spacelike nucleon form factors within light-front dynamics E. Pace (Rome U., Tor Vergata), G. Salme ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the 13 Biotech Stocks with Huge Upside Potential. The company ...
The newly redesigned Toyota 4Runner brings its cabin in line with other truckish Toyotas, including the Tacoma and the Sequoia. Do you like right angles and big screens? If so, you'll love the 2025 ...
Vertex Pharmaceuticals is getting bullish attention from analysts, especially Cantor Fitzgerald, which predicts earnings of ...
Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 11 10 June 2025Worldwide Healthcare Trust PLC(the "Company") Annual Financial ...
Vertex Pharmaceuticals continues to dominate biotech with its cystic fibrosis breakthroughs and pioneering gene-editing and ...
There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline ...
Rare disease patients demand compulsory licensing for life-saving drugs: Here’s why it’s significant
Petition in Karnataka HC asks Govt to invoke compulsory licensing clause that grants someone other than the patent holder the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results